Saturday is Drug Take Back Day, find a drop-off near you
Here are some of the locations in Utah where you can drop off your unneeded and expired prescription medication on Saturday. For locations not on this list, or to locate a drop-off near you, visit the .
The event will run between 10 a.m. and 2 p.m. in most locations; events with a different time will be noted. No needles or sharp objects will be accepted.
Received a call from SLCPD demanding money? Police say hang up
The Salt Lake City Police Department will participate in Drug Take Back Day at its Pioneer Precinct.
Salt Lake City Police Department Pioneer Precinct1040 West 700 S, Salt Lake City, Utah
The West Jordan and Draper Police Departments' Drug Take Back events will be held at Smith's.
Smith's Food and Drug5710 W 7800 S, West Jordan, Utah
Smith's Food and Drug212 E 12300 S, Draper, Utah
The South Salt Lake Police Department will be at Walgreens for their drop-off.
Walgreens3250 S 700 E, Salt Lake City, Utah
The Sandy Police Department will be at Sandy City Hall's east entrance.
Sandy City Hall10000 Centennial Pkwy, Sandy, Utah
Enforcement of REAL IDs go into effect soon, are you ready?
The is hosting several Drug Take Back Day drop-offs as well. The locations are as follows:
Spanish Fork Police Department789 W Center St, Spanish Fork, Utah
Walmart Supercenter949 Grassland Drive, American Fork, Utah
Macey's760 E Main St, Lehi, Utah
CVS5326 W 11000 N, Highland, Utah
Payson Market Pharmacy586 N Main St, Payson, Utah
Pleasant Grove Recreation Center547 S Locust Ave, Pleasant Grove, Utah
Springville Public Library45 S Main St, Springville, Utah
Vineyard City Hall125 South Main Street, Vineyard, Utah
Planned Parenthood of Utah to close 2 clinics following federal freeze on Title X funding
The Davis County Sheriff's Office will oversee drop-off at the Smith's in West Point.
Smith's Food and Drug217 N 2000 W, West Point, Utah
The Syracuse Police Department will host a Drug Take Back event at Walmart.
Syracuse Walmart2228 W 1700 S, Syracuse, UT 84075
The Kaysville Police Department will also have a drop-off location at Smith's.
Smith's Food and Drug1370 W 200 N, Kaysville, Utah
The Weber County Sheriff's Office will have officers running Drug Take Back Day. Officers will be in Plain City, and note that you can turn in vape devices if the lithium-ion batteries are removed.
Kent's Market3673 W 2600 N, Plain City, Utah
The Ogden Police Department will also be hosting two drop-off locations.
Smith's Food and Drug4275 Harrison Blvd, Ogden, Utah
Smith's Food and Drug1485 Harrison Blvd, Ogden, Utah
More than 200 intersections to close for Salt Lake City Marathon this weekend
The St. George and Hurricane Police Departments will both be hosting drop-offs.
Bloomington Walmart Supercenter2610 Pioneer Rd, St. George, Utah
Smith's Food and Drug20 N Bluff St, St. George, Utah
Lin's Market Hurricane1120 W State St, Hurricane, Utah
are hosting a few Drug Take Back Day events. Between 12 p.m. and 2 p.m. on April 26, you can visit one of the following locations to drop off your prescriptions. A free swag bag and food truck will be provided while supplies last.
Carbon County Sheriff's Office240 W Main St., Price, Utah
OK Anderson City Park100 Solomon Street, Green River, Utah
Stewart's Market580 E Main St, Castle Dale, Utah
Utahns among those paying the most in housing costs, study says
The Utah State University Department of Public Safety is hosting a drop-off in the basement of the student center on campus.
Glen L. Taggart Student Center650 N 800 E, Logan, Utah
The Uintah County Sheriff's Office will be at Walmart in Vernal.
Walmart Supercenter1851 U.S. Hwy 40, Vernal, Utah
The Tooele County Sheriff's Office will be in Stansbury Park for their Drug Take Back Day drop off.
Soelberg's Market6727 UT-36, Stansbury Park, Utah
List: Which foods contain the dyes that RFK wants eliminated in the US?
How will RFK Jr.'s autism data collection work?
Trump signals shift in tone on China tariffs
See how Advanced Window Products protects your home and your peace of mind
MISSING: 15-year-old girl last known to be in American Fork
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
a day ago
- The Hill
Senate panel rejects Trump cuts to NIH, other health agencies
The Senate Appropriations Committee rejected the Trump administration's massive proposed funding cut to the National Institutes of Health, advancing a measure that would increase the agency's budget by $400 million. The White House budget called for slashing NIH by $18 billion, a decrease of 40 percent. Instead, the committee advanced the bill on a 26-3 vote, delivering a bipartisan rebuke of the administration's efforts to defund medical research. 'This committee has had multiple hearings over the last several months and heard from patients, families and researchers about the importance of NIH funding,' said Sen. Tammy Baldwin (D-Wis.). 'This committee has, in a bipartisan manner, prioritized NIH and the research it supports to develop life-saving treatments and cures for devastating diseases.' The committee rejected the administration's plan to revamp the way NIH pays universities, medical schools, and other research centers for overhead costs, as well as a proposal to restructure the agency and consolidate all 27 NIH institutes into eight new entities. The bill includes a $100 million increase for Alzheimer's disease research, a $150 million increase for cancer research, and a $30 million increase for the Office of Research on Women's Health. 'To the scientists wondering if there will even be an NIH by the end of this administration: this committee's resounding message is yes,' said Sen. Patty Murray (D-Wash.), the committee's vice chair. 'Congress has your back — we're not going to give up the fight against cancer, Alzheimer's, or rare diseases,' Murray said. Democratic committee members also expressed frustration at the White House Office of Management and Budget's (OMB) repeated encroachments into the appropriations process and attempts to halt spending of money that was already approved by Congress. Since President Trump took office, NIH has terminated or frozen nearly 5,000 awards totaling $4 billion, while another approximately $15 billion has not yet been obligated. 'Right now, they are illegally hiding apportionments data that would let us know whether funds we passed are being spent as intended and help us strengthen the bills we are in the middle of writing on. It is absurd we have to mark up bills, while being kept in the dark,' Murray said. Murray and other members repeatedly mentioned an OMB memo from earlier this week that, through a footnote, abruptly prevented NIH from issuing grants. While the decision was reversed, Democrats said it showed the administration's disdain for congressional spending authority. 'One footnote, from an unelected bureaucrat — overruling Congress and even NIH, to block $15 billion in funding for things like cancer research,' Murray said. Outside of NIH, the bill maintains flat funding for other health agencies and programs, including the Title X family planning program and domestic HIV prevention. The bill also rejected the nearly $4 billion — or 50 percent — cut and consolidation to Centers for Disease Control and Prevention programs included in the White House budget request. But looming over the process is the possibility of another rescissions package from the administration. 'Should the administration put forward a new rescissions package, in many cases, in our bill, we have rejected proposals that the President has made to make drastic cuts. That's Congress speaking up and saying we have a different position on that, and so I expect my Republican colleagues will stand by the decisions we've made,' Baldwin told reporters ahead of the hearing. Still, the HHS budget is far from being final. The House has so far only passed two of its annual funding bills, and has not held an Appropriations Committee markup on its version of the HHS bill.
The Hill
2 days ago
- The Hill
Safeguarding lives: The urgent need for congressional action on illicit Xylazine
America's opioid epidemic has entered a new and especially dangerous phase, as synthetic fentanyl and deadly additives devastate families and communities across the country. Congress must act now to equip law enforcement with the resources and tools they need to keep communities safe, while preventing unintended consequences on hardworking veterinarians, farmers and ranchers. Today, foreign manufactured, illicit fentanyl and fentanyl-related substances drive the opioid epidemic. Despite being 50 to 100 times stronger than their prescription counterparts, these synthetic opioids are often mixed with toxic cutting agents to increase potency and street value, while decreasing production costs. In recent years, cartels and criminal organizations have increasingly used xylazine, a powerful veterinary sedative, as a low-cost cutting agent for illicit fentanyl. This lethal combination is known as 'tranq.' Designated as an emerging threat to the United States in 2023, illicit xylazine poses grave health and safety risks when ingested by humans, including depressed breathing and heart rate, unconsciousness, severe necrosis and death. As of 2022, the Drug Enforcement Administration had seized xylazine and fentanyl mixtures in 48 states. At the same time, licit xylazine has been approved by the Food and Drug Administration for veterinary use since 1972 and remains a critical tool for veterinarians, farmers and ranchers. They use this drug to treat livestock and wildlife. In cattle, xylazine is the only safe and effective drug. There is no alternative. Currently, the DEA is in the process of making xylazine a controlled substance; however, scheduling xylazine without protecting its legitimate use may limit veterinary professionals' ability to treat animals and could increase the risk of supply disruption. Further, given xylazine is a low-volume, low-margin, generic animal drug, high regulatory burdens could force the few remaining domestic manufacturers to discontinue production altogether. Congress must fight the spread of illicit xylazine while preserving its veterinary use. That's why, over the last two years, we've worked with congressional colleagues, federal agencies and stakeholders like the American Veterinary Medical Association to craft a solution that achieves both goals, titled the Combating Illicit Xylazine Act. Our bipartisan, bicameral bill classifies xylazine as a Schedule III drug under the Controlled Substances Act, and contains several statutory provisions to preserve veterinary professionals' access and provide the DEA transparency into xylazine's market. This added market transparency would allow law enforcement to better track the legitimate sales of xylazine, as well as how the drug is diverted to the black market or illegally imported from China. Last Congress, language containing core components of the Combating Illicit Xylazine Act passed the House of Representatives with overwhelming bipartisan support. This Congress, we reintroduced the bill with updated language to strengthen its provisions. Our legislation is supported by the DEA, multiple law enforcement organizations, including the National Fraternal Order of Police, the National Association of Attorneys General and 30 state attorneys general, and all 50 state veterinary medical organizations. Attorney General Pam Bondi also advocated for the scheduling of xylazine on her first day in office. More than half of states have passed, proposed or implemented xylazine-related legislation or regulations. Passing the Combating Illicit Xylazine Act would alleviate this growing patchwork of state-by-state xylazine restrictions. Congressional inaction would compromise the DEA's ability to effectively combat the ongoing drug epidemic and weaken the nation's public health infrastructure. The Combating Illicit Xylazine Act is a commonsense solution that will help keep deadly xylazine off the streets, without threatening the livelihood of farmers and ranchers nationwide. We urge our colleagues in Congress to join us in support of this legislation and work swiftly to pass it into law.
Yahoo
2 days ago
- Yahoo
US health officials crack down on kratom-related products after complaints from supplement industry
WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban. The chemical, known as 7- hydroxymitragynine, is a component of kratom, a plant native to Southeast Asia that has gained popularity in the U.S. as an unapproved treatment for pain, anxiety and drug dependence. In recent months, dietary supplement companies that sell kratom have been urging the Food and Drug Administration to crack down on the products containing 7-OH, portraying it as a dangerously concentrated, synthetic form of the original ingredient. The FDA action 'is not focused on natural kratom leaf products," according to a statement Tuesday by the U.S. Department of Health and Human Services. The agency said it was releasing a report to educate about the risks of '7-OH and its distinction from the kratom plant leaf.' Regulators are also recommending that the ingredient be placed on the federal government's most restrictive list of illegal drugs, which includes LSD and heroin. '7-OH is an opioid that can be more potent than morphine," said FDA Commissioner Marty Makary. "We need regulation and public education to prevent another wave of the opioid epidemic.' The agency's recommendation will be reviewed by the Drug Enforcement Administration, which sets federal rules for high-risk drugs including prescription medicines and illicit substances. A national ban wouldn't take effect until the agency drafts and finalizes new rules governing the ingredient. Federal regulators have been scrutinizing kratom for about a decade after reports of addiction, injury and overdose. But users and distributors have long opposed efforts to regulate it, saying kratom could be a safer alternative to opioid painkillers that sparked the ongoing drug addiction epidemic. Last month, the FDA issued warning letters to seven companies selling drinks, gummies and powders infused with 7-OH. Regulators said the products violated FDA rules because they have not been evaluated for safety and, in some cases, claimed to treat medical conditions, including pain, arthritis and anxiety. Supplement executives quickly applauded the move. The FDA "demonstrated the exact kind of data-driven, proactive regulatory excellence needed to safeguard unwitting consumers across the U.S.,' said Ryan Niddel of Diversified Botanics, a Utah-based company that sells kratom supplements. An industry group, the American Kratom Association, has lobbied Congress for years against restrictions on the plant. Legislation supported by the group would prohibit the FDA from regulating kratom more strictly than food and dietary supplements. In recent years, the association has lobbied at the state level for bills that limit synthetic 7-OH products. On Tuesday, a rival group that supports the availability of 7-OH drugs criticized the government's move, pointing to the influence of kratom suppliers. 'Big kratom trade groups have spent years blaming 7-OH for harms caused by their own unregulated products, because it threatens their market share,' the Holistic Alternative Recovery Trust stated in an emailed message. Nearly a decade ago, the federal government came close to banning kratom. In 2016, the DEA announced plans to add it to the government's most restrictive schedule 1, reserved for drugs that have no medical use and a high potential for abuse. But the plan stalled after a flood of public complaints, including a letter signed by more than 60 members of Congress. The FDA then began studying the ingredient, concluding in 2018 that kratom contains many of the same chemicals as opioids, the addictive class of drugs that includes painkillers like OxyContin as well as heroin and fentanyl. Since then, FDA regulators have continued to issue warnings about cases of injury, addiction and death with kratom supplements, which are usually sold in capsules or powders. In recent months, the FDA has also issued warnings on other unapproved drugs sold as supplements or energy drinks, including the antidepressant tianeptine. Sometimes referred to collectively as 'gas station heroin,' the drugs have been restricted by several states, but they are not scheduled at the federal level. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Matthew Perrone, The Associated Press
